Integra LifeSciences(IART) - 2024 Q1 - Quarterly Results

Total reported revenues of $368.9 million declined 3.1% on a reported basis and declined 2.5% on an organic basis compared to the prior year. Organic growth excluding Boston was 1.6%. Revenue exceeded the outlook the Company provided in February. The Company reported GAAP gross margin of 56.1%, compared to 61.1% in the first quarter of 2023. Adjusted gross margin was 64.4%, compared to 67.3% in the prior year. Integra LifeSciences Reports First Quarter 2024 Financial Results PRINCETON, N.J., May 6, 2024 - I ...